Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -57.20M
March 31, 2026 6.60M
December 31, 2025 105.20M
September 30, 2025 37.00M
June 30, 2025 200.40M
March 31, 2025 149.30M
December 31, 2024 83.00M
September 30, 2024 99.70M
June 30, 2024 23.30M
March 31, 2024 90.60M
December 31, 2023 280.20M
September 30, 2023 369.20M
June 30, 2023 318.00M
March 31, 2023 573.23M
December 31, 2022 885.30M
September 30, 2022 1.037B
June 30, 2022 1.124B
March 31, 2022 721.38M
December 31, 2021 805.87M
September 30, 2021 923.62M
June 30, 2021 917.02M
March 31, 2021 1.154B
December 31, 2020 629.76M
September 30, 2020 237.62M
June 30, 2020 180.50M
Date Value
March 31, 2020 162.04M
December 31, 2019 133.75M
September 30, 2019 129.98M
June 30, 2019 122.80M
March 31, 2019 132.92M
December 31, 2018 135.83M
September 30, 2018 103.84M
June 30, 2018 90.16M
March 31, 2018 33.95M
December 31, 2017 27.71M
September 30, 2017 33.10M
June 30, 2017 38.28M
March 31, 2017 48.99M
December 31, 2016 11.75M
September 30, 2016 9.441M
June 30, 2016 5.73M
March 31, 2016 -6.181M
December 31, 2015 33.24M
September 30, 2015 39.30M
June 30, 2015 45.55M
March 31, 2015 47.45M
December 31, 2014 37.84M
September 30, 2014 18.94M
June 30, 2014 13.66M
March 31, 2014 13.39M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 1.368B
Neogen Corp. 83.20M
Aspira Women's Health, Inc. -4.562M
VolitionRX Ltd. -18.84M
Lucid Diagnostics, Inc. -46.87M